In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis-Reference-Cited by-同舟云学术

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Published:2016-03-09 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Bulfoni Michela,Gerratana Lorenzo,Del Ben Fabio,Marzinotto Stefania,Sorrentino Marisa,Turetta Matteo,Scoles Giacinto,Toffoletto Barbara,Isola Miriam,Beltrami Carlo Alberto,Di Loreto Carla,Beltrami Antonio Paolo,Puglisi Fabio,Cesselli Daniela

Funder

AIRC 5 per mille

FIRB Accordi di programma 2011

ERC- 7FP SP 2 IDEAS

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0687-3.pdf

Reference38 articles.

1. Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14(9):623–31.

2. Plaks V, Koopman CD, Werb Z. Cancer. Circulating tumor cells. Science. 2013;341(6151):1186–8.

3. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539–44.